Skip to content

Clinical trials

Phase 4 Major Depressive Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 4 Country / region: United States Clear all

185 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20025
20034
20046
200511
200614
200712
200811
20098
201012
20118
20128
20136
20148
20157
20169
20177
20183
201910
20204
20212
20226
20234
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed138
Terminated21
Recruiting9
Unknown status8
Withdrawn5
Active, not recruiting2
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute28
University of California, Los Angeles15
Massachusetts General Hospital12
Emory University7
Forest Laboratories6
University of Pittsburgh6
University of Texas Southwestern Medical Center6
Eli Lilly and Company5
Mclean Hospital5
National Institute of Mental Health (NIMH)4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder185
Bipolar Disorder12
Depressive Disorder10
Dysthymic Disorder10
Anxiety Disorders9
Depressive Disorder, Treatment-Resistant9
Schizophrenia7
Psychotic Disorders6
Diabetes Mellitus4
Mood Disorders4

Trials

Showing 1 to 25 of 185. Each trial links to its page on Pharma Observatory.

85 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.